In the last three months, 8 analysts have published ratings on United Therapeutics (NASDAQ:UTHR), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 2 | 1 | 1 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 1 | 0 |
| 2M Ago | 2 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $356.38, a high estimate of $400.00, and a low estimate of $280.00. Observing a 11.46% increase, the current average has risen from the previous average price target of $319.75.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial...
Login or create a forever free account to read this news
Sign up/Log in
